Company Profile for Kubota Vision Inc. (dba of Acucela Inc.)

--(BUSINESS WIRE)--Kubota Vision Inc. is a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596) committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of people worldwide. Kubota Vision’s development pipeline include drug candidates for the treatment of diabetic retinopathy, Stargardt disease, and optogenetics-based gene therapy for the treatment of retinitis pigmentosa. The company is also developing a handheld OCT device for the monitoring of neovascular retinal diseases, to be used directly by patients.

Company:	Kubota Vision Inc. (dba of Acucela Inc.)
Headquarters Address:	818 Stewart Street, Suite 1110
	Seattle, WA 98101
Main Telephone:	+1.206.805.8300
Website:	https://www.kubotavision.com/
Type of Organization:	Private
Industry:	Biotechnology, Medical Devices, Pharmaceutical
Key Executives:	CEO: Ryo Kubota
Investor Relations
Contact:	Hiroki Maekawa
Phone:	+81.3.6550.8928
Email:	[e-mail]
Public Relations
Contact:	Yumiko Hamanaka
Phone:	+1.206.805.8300
Email:	[e-mail]
Business Development
Contact:	- -
Email:	[e-mail]